BEOGUT 500MG/SACHET POWDER

Indications

• Prevention and treatment of antibiotic-associated diarrhea
• Management of irritable bowel syndrome (IBS)
• Support for gastrointestinal health
• Enhancement of immune function
• Lactose intolerance management

Dosage

Children: Refer to specific product guidelines, as doses can vary by formulation and indication.

Adults: Refer to specific product guidelines, as doses can vary by formulation and indication.

Mechanism of action

Bifidobacterium exerts its beneficial effects primarily through the modulation of the gut microbiota. It helps to inhibit the growth of pathogenic bacteria by producing organic acids, such as lactic acid and acetic acid, which lower the pH of the gut environment. Additionally, Bifidobacterium enhances the intestinal barrier function, promotes the production of mucus, and stimulates the immune response by interacting with gut-associated lymphoid tissue (GALT).

Pharmacodynamics

The pharmacodynamic effects of Bifidobacterium are characterized by its ability to restore and maintain the balance of gut microbiota, enhance intestinal barrier function, and modulate immune responses. Probiotics like Bifidobacterium can help reduce gastrointestinal symptoms, such as diarrhea and constipation, and have been associated with improvements in lactose digestion and overall gut health.

Pharmacokinetics

Bifidobacterium is not absorbed systemically; rather, it acts locally within the gastrointestinal tract. Its survival and efficacy can be influenced by factors such as the strain of bacteria, the presence of prebiotics, and the overall health of the digestive system. The bacteria can colonize the gut temporarily, providing a local effect, but regular intake is often necessary to maintain its benefits.

Adverse effects

• Bloating
• Gas
• Diarrhea
• Constipation

Precautions

• Patients with weakened immune systems should use caution as probiotics may lead to infections.
• Those with severe allergies should consult a healthcare provider before use.

Pregnancy

Generally considered safe for use during pregnancy, but it is advisable to consult a healthcare professional before starting.

Breast-feeding

Typically safe for breastfeeding mothers, but it is recommended to seek medical advice.

Storage

Store in a cool, dry place. Some formulations may require refrigeration.

Formulations

• Capsules
• Powders
• Tablets
• Liquid suspensions

Indications

• Inflammatory bowel disease
• Ulcerative colitis
• Crohn's disease
• Colorectal cancer prevention
• Gut health improvement

Dosage

Children: Refer to professional guidelines for specific dosing recommendations as it may vary based on the condition being treated and formulation used.

Adults: Refer to professional guidelines for specific dosing recommendations as it may vary based on the condition being treated and formulation used.

Mechanism of action

Butyricum exerts its effects primarily through the activation of G-protein coupled receptors (GPCRs), particularly the free fatty acid receptors (FFAR) such as FFAR2 and FFAR3. It also influences histone deacetylase (HDAC) activity, leading to altered gene expression. These mechanisms contribute to its anti-inflammatory properties and its role in regulating gut barrier function.

Pharmacodynamics

Butyricum is known to enhance colonic mucosal integrity and reduce inflammation by influencing immune cell activity. It promotes the production of mucus and the proliferation of colonic epithelial cells, contributing to the maintenance of a healthy gut environment. Furthermore, it has been shown to modulate metabolic processes, influencing insulin sensitivity and lipid metabolism.

Pharmacokinetics

Butyric acid is rapidly absorbed and metabolized in the intestines, with a short half-life. It is primarily distributed in the gut, where it acts locally, but it can also enter systemic circulation in small amounts. Its effects are predominantly localized to the gastrointestinal tract, where it contributes to the health of the intestinal lining and modulates gut microbiota composition.

Pregnancy

Safety during pregnancy has not been established. Consult healthcare providers before use.

Breast-feeding

Safety during breastfeeding has not been established. Consult healthcare providers before use.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Botulism
• Tetanus
• Clostridium difficile infection
• Pseudomembranous colitis

Dosage

Adults: Refer to specific clinical guidelines for dosage based on the condition being treated, as Clostridium infections require targeted therapies and may involve antitoxins, antibiotics, or supportive

Mechanism of action

Clostridium species produce potent exotoxins that interfere with normal cellular functions. For instance, Clostridium botulinum produces botulinum toxin, which inhibits acetylcholine release at the neuromuscular junction, leading to paralysis. Clostridium tetani produces tetanospasmin, which blocks inhibitory neurotransmitter release in the central nervous system, resulting in muscle spasms. Clostridium difficile releases toxins A and B, which disrupt the intestinal epithelium and cause inflammation, leading to diarrhea.

Pharmacodynamics

The pharmacodynamic effects of Clostridium toxins are primarily driven by their enzymatic activities. Botulinum toxin is the most potent toxin known and acts at neuromuscular junctions, causing flaccid paralysis. Tetanospasmin affects central nervous system neurotransmission, leading to spastic paralysis. Toxins produced by Clostridium difficile lead to cell death and inflammatory responses in the colon, contributing to pseudomembranous colitis.

Pharmacokinetics

The pharmacokinetics of Clostridium infections vary by species and toxin type. Generally, the toxins are absorbed into circulation following local release at infection sites. For example, botulinum toxin is absorbed through the gastrointestinal tract when ingested and distributed throughout the body, while tetanospasmin acts locally and is transported retrograde along motor neurons to the central nervous system. The duration of action is influenced by the toxin's ability to bind to receptors and enter cells, as well as the body's capacity for toxin clearance.

Pregnancy

The safety of clostridium species during pregnancy has not been established. Caution is advised when administering to pregnant individuals.

Breast-feeding

The effects of clostridium species during breastfeeding are not well studied. Caution is recommended.

Storage

Store in a cool, dry place away from direct sunlight. Specific storage conditions may vary based on formulation.